longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy
Reuters
Aug 5, 2026 at 12:03 PM

Due to the copyright holder's request, this page is temporarily unavailable.

Recommended Readings

  • Feb 10, 2026 at 01:42 PMGlobal news you need to know before the U.S. stock market opens on Tuesday
  • Feb 10, 2026 at 08:30 AMAfter investing $18.5 billion to partner with Stone Group, AstraZeneca's earnings per share are expected to increase by …
  • Jan 7, 2026 at 08:30 AMWill GLP-1 spillover and AI empowerment make biomedicine the "alternative" for tech stocks in 2026?
  • Nov 11, 2025 at 01:51 PMConsolidating its position as the "largest heavyweight stock" in the UK market, pharmaceutical giant Astrazeneca's stock…

Related Stocks

AstraZeneca

AstraZeneca

USAZN

+2.25%

Bristol Myers Squibb

Bristol Myers Squibb

USBMY

+0.72%

AstraZeneca PLC

AstraZeneca PLC

UKAZN

LongbridgeAI